Robert W.a. Sellers - 28 Apr 2023 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Signature
Linda J. Park, Attorney-in-Fact
Issuer symbol
EW
Transactions as of
28 Apr 2023
Net transactions value
-$638,080
Form type
4
Filing time
28 Apr 2023, 19:08:08 UTC
Previous filing
17 May 2022
Next filing
04 May 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $431,864 +12,270 +104% $35.20 24,020 28 Apr 2023 Direct
transaction EW Common Stock Sale $1,069,944 -12,270 -51% $87.20 11,750 28 Apr 2023 Direct
holding EW Common Stock 20,409 28 Apr 2023 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -12,270 -100% $0.000000* 0 28 Apr 2023 Common Stock 12,270 $35.20 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.